Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder-Reference-Cited by-同舟云学术

Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder

Published:2017-08-01 Issue:8 Volume:74 Page:833
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Attwells Sophia¹,Setiawan Elaine²,Wilson Alan A.³,Rusjan Pablo M.²,Mizrahi Romina⁴,Miler Laura²,Xu Cynthia²,Richter Margaret Anne⁵,Kahn Alan³,Kish Stephen J.⁴,Houle Sylvain³,Ravindran Lakshmi⁶,Meyer Jeffrey H.⁴

Affiliation:

1. Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada2Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada

2. Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada

3. Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada3Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

4. Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada2Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada3Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

5. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada4Frederick W. Thompson Anxiety Disorders Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

6. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of maternal obsessive‐compulsive disorder (OCD) on feto‐maternal outcomes: A systematic review and meta‐analysis;International Journal of Gynecology & Obstetrics;2024-07-15

2. Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression;European Archives of Psychiatry and Clinical Neuroscience;2024-07-08

3. Altered serum interleukin-17A and interleukin-23A levels may be associated with the pathophysiology and development of generalized anxiety disorder;Scientific Reports;2024-07-02

4. Exploring the role of interleukin-1β and interleukin-6 in the pathophysiology of obsessive-compulsive disorder;PLOS ONE;2024-06-26

5. Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder;Frontiers in Psychiatry;2024-06-11